Sonova Holding AG (SONVY)
63.42
-0.80
(-1.25%)
USD |
OTCM |
May 20, 16:05
Sonova Total Liabilities (Quarterly): 3.658B for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.658B |
| September 30, 2023 | 3.559B |
| September 30, 2023 | 3.559B |
| March 31, 2023 | 3.636B |
| September 30, 2022 | 3.278B |
| September 30, 2022 | 3.278B |
| March 31, 2022 | 3.418B |
| September 30, 2021 | 3.389B |
| September 30, 2021 | 3.389B |
| March 31, 2021 | 3.347B |
| September 30, 2020 | 3.443B |
| September 30, 2020 | 3.443B |
| March 31, 2020 | 2.559B |
| September 30, 2019 | 2.279B |
| September 30, 2019 | 2.279B |
| March 31, 2019 | 1.925B |
| September 30, 2018 | 1.988B |
| September 30, 2018 | 1.988B |
| March 31, 2018 | 1.916B |
| September 30, 2017 | 1.876B |
| September 30, 2017 | 1.876B |
| Date | Value |
|---|---|
| March 31, 2017 | 1.803B |
| September 30, 2016 | 1.903B |
| September 30, 2016 | 1.903B |
| March 31, 2016 | 875.95M |
| September 30, 2015 | 869.69M |
| September 30, 2015 | 869.69M |
| March 31, 2015 | 847.21M |
| September 30, 2014 | 790.76M |
| September 30, 2014 | 790.76M |
| March 31, 2014 | 923.84M |
| September 30, 2013 | 1.098B |
| September 30, 2013 | 1.098B |
| March 31, 2013 | 1.094B |
| September 30, 2012 | 833.89M |
| September 30, 2012 | 833.89M |
| March 31, 2012 | 889.47M |
| September 30, 2011 | 886.61M |
| March 31, 2011 | 899.87M |
| September 30, 2010 | 934.30M |
| March 31, 2010 | 1.007B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.279B
Minimum
Sep 2019
3.658B
Maximum
Mar 2024
3.234B
Average
3.389B
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| AC Immune SA | 25.05M |
| CRISPR Therapeutics AG | 355.08M |
| Addex Therapeutics Ltd | 4.163M |
| NLS Pharmaceutics Ltd | 10.68M |
| Molecular Partners AG | 26.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.419B |
| Shareholders Equity (Quarterly) | 2.738B |
| Debt to Equity Ratio | 0.6135 |
| Current Ratio | 1.452 |
| Net Debt Paydown Yield | -3.24% |